The reformulated vaccine defends against new omicron strains, including XBB omicron variants. The panel stopped short of ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

California state leaders seem to be quietly closing the door on the COVID-19 vaccine mandate for school children. The ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The Vaccines and Related Biological Products Advisory Committee meets Thursday to consider how to update guidelines for COVID ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

The Food and Drug Administration's proposal was outlined in its briefing documents ahead of a meeting of its panel of ...

Six of the eight studies showed the bivalent booster is more effective against the BA.5 variant, compared to the original booster shots ... of COVID-19 Vaccinations in the U.S.” FDA: “Vaccine ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...